Innovation
2 patent families — focus: Human necessities; filing pace slowing. Cited 7 times.
| Year | Filings |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |
Company developing lysin based therapeutics for treating infectious diseases caused by bacteria
2 patent families — focus: Human necessities; filing pace slowing. Cited 7 times.
| Year | Filings |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |